Skip to search formSkip to main contentSkip to account menu

melan-A VLP vaccine

Known as: CYT004-MelQbG10 
A vaccine consisting of the melanocyte differentiation antigen Melan A (also called MART-1) encapsulated in noninfectious virus-like particles (VLP… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
• Rose, S., Niyazov, D.M., Rossignol, D.A. et al. Clini cal and Molec ular Chara cteri stics of Mitoc hondr ial Dysfu nctio n in… 
2018
2018
Recurrence of distinct strains of seasonal influenza viruses requires the development of universal vaccines. Previous studies… 
2015
2015
Problems associated with poor pharmacokinetics and biodistribution, as well as toxic off-target effects, limit the curative… 
2014
2014
Purpose:We initially observed that the presence of circulating NY-ESO-1– and/or Melan-A–specific T cells in patients with stage… 
2014
2014
Almost all cervical cancers are caused by persistent human papillomaviruses (HPV) infection, most often HPV16. Considerable… 
2013
2013
Pr55gag Virus-ahnliche Partikel (VLP) stellen eine innovative Form einer HIV-Vakzine dar, die hoch-immunogene Eigenschaften… 
2007
2007
ZusammenfassungDie neuen HPV-Vakzinen sind Spaltvakzinen und bestehen aus dem L1-Hauptkapsidprotein, das spontan nach… 
2006
2006
본 발명은 신규하고 비감염성인 파라믹소바이러스 백신의 제조 방법 및 사용 방법을 기재한다. 바이러스-유사 입자 (VLP… 
2004
2004
i. C.-G. Esseen and S. Janson, "On moment conditions for normed sums of independent variables and Martingale difference… 
Review
1978
Review
1978
Th e commo n neopl asms of sheep include intestina l ade nocarcino ma [1, 6, 14] and lymphosarcoma and hepatic ca rcino ma [1, 5…